Clinical trialNCT06523777Active, not recruitingObservational

PRISM: Patient Experiences With PET Imaging in Prostate Cancer

SponsorYale UniversityEnrollment350Prostate Cancer

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to examine patient experiences, health-related quality of life, and decision-making associated with PET imaging for prostate cancer. In particular, Prostate Specific Membrane Antigen (PSMA) PET, a new and more sensitive form of imaging that can help identify metastatic cancer earlier and more reliably.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Michael Leapman, MD
Yale University
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Yale New Haven Health Bridgeport Hospital - Park Ave Medical Center
Bridgeport, Connecticut, United States
Griffin Hospital
Derby, Connecticut, United States
Yale New Haven Health Greenwich Hospital
Greenwich, Connecticut, United States
Radiology and Biomedical Imaging - New Haven - Smilow Cancer Hospital (north Pavilion):
New Haven, Connecticut, United States
Saint Raphael'S Radiology and Biomedical Imaging, Basement Location.
New Haven, Connecticut, United States
Yale New Haven Health Lawrence & Memorial Hospital
New London, Connecticut, United States
Yale New Haven Health Westerly Hospital
Westerly, Rhode Island, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 25 Jul 2024
Primary completion: 25 Jul 2027
Completion: 25 Jul 2028
Last update posted: 28 May 2026
Registered enrollment: 350
Registry id: NCT06523777

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.